Boric acid
USP/1076341 - United States Pharmacopeia (USP) Reference Standard
CAS Number: 10043-35-3
Empirical Formula (Hill Notation): H3BO3
Molecular Weight: 61.83
MDL Number: MFCD00011337
Linear Formula: H3BO3
Product Type: Chemical
| API family | boric acid |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| density | 1.440 g/cm3 |
| form | crystalline |
| solid | |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/BH3O3/c2-1(3)4/h2-4H |
| InChI key | KGBXLFKZBHKPEV-UHFFFAOYSA |
| manufacturer/tradename | USP |
| mp | 160 °C (dec.) (lit.) |
| SMILES string | OB(O)O |
| solubility | boiling water: freely soluble |
| ethanol: soluble | |
| glycerol: freely soluble | |
| vapor pressure | 2.6 mmHg ( 20 °C) |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Boric acid USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Dalteparin Sodium |
| General description: | Boric acid is a weak, monobasic Lewis acid of boron with mild antiseptic, antifungal, and antiviral properties. It is employed in various pharmaceutical and cosmetic products for its buffering and antimicrobial characteristics. Boric acid is used as a buffering agent in culture media and can act as a preservative to prevent bacterial and fungal growth. not a USP categoty The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| General description: | This compound is listed in the SVHC (Substances of very high concern) candidate list   of ECHA (European Chemicals Agency) |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This compound is listed in the SVHC (Substances of very high concern) candidate list of ECHA (European Chemicals Agency) |
| Other Notes: | This product is part of the USP Biologics program. |
| Other Notes: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
| Symbol |  GHS08 |
| Signal word | Danger |
| Hazard statements | H360FD |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 160 °C (dec.) (lit.) |
| Density | 1.440 g/cm3 |
| UNSPSC | 41116107 |